Avalyn Pharma's Series A Round

Avalyn Pharma raised a round of funding on March 24, 2017.

Avalyn Pharma, fka Genoa Pharmaceuticals, is a pharmaceutical company committed to developing improved therapies for the treatment of Idiopathic Pulmonary Fibrosis (IPF). The company's lead program (A…

Articles about Avalyn Pharma's Series A Round: